This definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Luminex Corporation is valued at $642,450.00. The contract supports the development of Luminex's ARIES SARS-CoV-2 assay under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002. Special Instructions 019 revised the description for mitigating long-term effects of respiratory distress and updated submission deadlines for abstracts related to host-directed therapeutic candidates aiding recovery from lung injury. The place of performance is Austin, Texas, with work to be completed between March and August 2020. As a firm fixed price contract, Luminex will deliver its ARIES SARS-CoV-2 assay to address the coronavirus pandemic while pursuing safety review through Phase I and sharing subsequent data and commercialization plans with HHS.